CS202545B2 - Method of preparing living vaccine from influenza virus for nasal application - Google Patents

Method of preparing living vaccine from influenza virus for nasal application Download PDF

Info

Publication number: CS202545B2
Authority: CS; Czechoslovakia
Prior art keywords: strain; virus; influenza; atcc; attenuated
Prior art date: 1974-02-04

Application number

CS75669A

Other languages

Czech (cs)

English (en)

Inventor

Julien Peetermans

Michele Lobmann

Jean-Marie Prevost

Emil Vascoboinic

Original Assignee

Rit Rech Ind Therapeut

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-02-04

Filing date

1975-02-03

Publication date

1981-01-30

1975-02-03 Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut

1981-01-30 Publication of CS202545B2 publication Critical patent/CS202545B2/cs

Links

229960005486 vaccine Drugs 0.000 title claims abstract description 40
241000712461 unidentified influenza virus Species 0.000 title claims description 23
238000000034 method Methods 0.000 title claims description 17
241000700605 Viruses Species 0.000 claims abstract description 41
241000287828 Gallus gallus Species 0.000 claims abstract description 31
230000002238 attenuated effect Effects 0.000 claims abstract description 30
239000000203 mixture Substances 0.000 claims abstract description 20
239000001888 Peptone Substances 0.000 claims abstract description 19
108010080698 Peptones Proteins 0.000 claims abstract description 19
235000019319 peptone Nutrition 0.000 claims abstract description 19
206010022000 influenza Diseases 0.000 claims abstract description 14
239000003381 stabilizer Substances 0.000 claims abstract description 9
230000000890 antigenic effect Effects 0.000 claims abstract description 6
239000004480 active ingredient Substances 0.000 claims abstract description 5
241000713196 Influenza B virus Species 0.000 claims description 20
238000002360 preparation method Methods 0.000 claims description 19
241000712431 Influenza A virus Species 0.000 claims description 7
238000005215 recombination Methods 0.000 claims description 7
230000006798 recombination Effects 0.000 claims description 7
239000000463 material Substances 0.000 claims description 5
241000283690 Bos taurus Species 0.000 claims description 3
239000000758 substrate Substances 0.000 claims description 3
210000003837 chick embryo Anatomy 0.000 claims description 2
208000037797 influenza A Diseases 0.000 claims description 2
230000008569 process Effects 0.000 claims description 2
210000005084 renal tissue Anatomy 0.000 claims description 2
235000013330 chicken meat Nutrition 0.000 claims 3
229940031567 attenuated vaccine Drugs 0.000 claims 1
210000003754 fetus Anatomy 0.000 claims 1
235000013601 eggs Nutrition 0.000 abstract description 29
229940124873 Influenza virus vaccine Drugs 0.000 abstract description 6
241000701076 Macacine alphaherpesvirus 1 Species 0.000 abstract description 4
229960003971 influenza vaccine Drugs 0.000 abstract description 2
239000003550 marker Substances 0.000 abstract 1
210000002966 serum Anatomy 0.000 description 33
239000012530 fluid Substances 0.000 description 20
210000002257 embryonic structure Anatomy 0.000 description 19
239000002054 inoculum Substances 0.000 description 13
239000000725 suspension Substances 0.000 description 10
238000010790 dilution Methods 0.000 description 9
239000012895 dilution Substances 0.000 description 9
238000002255 vaccination Methods 0.000 description 9
230000003612 virological effect Effects 0.000 description 9
239000011521 glass Substances 0.000 description 8
239000003112 inhibitor Substances 0.000 description 8
210000003928 nasal cavity Anatomy 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
241001494479 Pecora Species 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
238000011534 incubation Methods 0.000 description 6
238000011081 inoculation Methods 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
239000000243 solution Substances 0.000 description 6
241000831652 Salinivibrio sharmensis Species 0.000 description 5
230000000694 effects Effects 0.000 description 5
210000003743 erythrocyte Anatomy 0.000 description 5
230000035931 haemagglutination Effects 0.000 description 5
230000036512 infertility Effects 0.000 description 5
241001465754 Metazoa Species 0.000 description 4
244000052616 bacterial pathogen Species 0.000 description 4
230000001717 pathogenic effect Effects 0.000 description 4
241000282339 Mustela Species 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000009021 pre-vaccination Methods 0.000 description 3
241000271566 Aves Species 0.000 description 2
101710154606 Hemagglutinin Proteins 0.000 description 2
101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
101710176177 Protein A56 Proteins 0.000 description 2
210000001643 allantois Anatomy 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
238000003556 assay Methods 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000001747 exhibiting effect Effects 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000000185 hemagglutinin Substances 0.000 description 2
230000036039 immunity Effects 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
239000000047 product Substances 0.000 description 2
230000000405 serological effect Effects 0.000 description 2
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
241000353621 Eilat virus Species 0.000 description 1
241001500351 Influenzavirus A Species 0.000 description 1
241001500350 Influenzavirus B Species 0.000 description 1
241000282341 Mustela putorius furo Species 0.000 description 1
206010028735 Nasal congestion Diseases 0.000 description 1
206010062106 Respiratory tract infection viral Diseases 0.000 description 1
208000036071 Rhinorrhea Diseases 0.000 description 1
206010039101 Rhinorrhoea Diseases 0.000 description 1
230000027645 antigenic variation Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
229940031416 bivalent vaccine Drugs 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
238000009835 boiling Methods 0.000 description 1
244000309464 bull Species 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
230000029142 excretion Effects 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
230000035876 healing Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
229940031551 inactivated vaccine Drugs 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
208000037798 influenza B Diseases 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
229960001226 live attenuated influenza Drugs 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
239000012528 membrane Substances 0.000 description 1
229940037525 nasal preparations Drugs 0.000 description 1
210000001989 nasopharynx Anatomy 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
244000052769 pathogen Species 0.000 description 1
229940066779 peptones Drugs 0.000 description 1
239000008063 pharmaceutical solvent Substances 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
238000000746 purification Methods 0.000 description 1
210000001533 respiratory mucosa Anatomy 0.000 description 1
230000004044 response Effects 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000004448 titration Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Virology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CS75669A 1974-02-04 1975-02-03 Method of preparing living vaccine from influenza virus for nasal application CS202545B2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US43917674A	1974-02-04	1974-02-04

Publications (1)

Publication Number	Publication Date
CS202545B2 true CS202545B2 (en)	1981-01-30

Family

ID=23743623

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CS75669A CS202545B2 (en)	1974-02-04	1975-02-03	Method of preparing living vaccine from influenza virus for nasal application

Country Status (21)

Country	Link
JP (1)	JPS50107122A (fr)
AT (1)	AT338416B (fr)
BE (1)	BE824970A (fr)
CA (1)	CA1047922A (fr)
CH (1)	CH596316A5 (fr)
CS (1)	CS202545B2 (fr)
DD (1)	DD116474A5 (fr)
DE (1)	DE2504373A1 (fr)
DK (1)	DK141926B (fr)
ES (1)	ES434384A1 (fr)
FI (1)	FI750260A7 (fr)
FR (1)	FR2259616B1 (fr)
GB (1)	GB1439742A (fr)
HU (1)	HU170522B (fr)
IE (1)	IE42043B1 (fr)
IL (1)	IL46446A (fr)
LU (1)	LU71784A1 (fr)
NL (1)	NL7501028A (fr)
NO (1)	NO750295L (fr)
SE (1)	SE424503B (fr)
ZA (1)	ZA75248B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2588918A (en) *	1947-11-07	1952-03-11	William T Graham	Mechanism for raising and lowering plow frames relative to the ground wheels
JPS6042209B2 (ja) *	1974-05-31	1985-09-20	北里研究所（社団法人）	インフルエンザウイルスの新鮮分離株を発育鶏卵へ短期間で順化させる方法

1975
- 1975-01-14 ZA ZA00750248A patent/ZA75248B/xx unknown
- 1975-01-16 IL IL46446A patent/IL46446A/xx unknown
- 1975-01-16 DK DK9775AA patent/DK141926B/da not_active IP Right Cessation
- 1975-01-20 SE SE7500549A patent/SE424503B/xx unknown
- 1975-01-23 CA CA218,508A patent/CA1047922A/fr not_active Expired
- 1975-01-24 FR FR7502331A patent/FR2259616B1/fr not_active Expired
- 1975-01-27 IE IE160/75A patent/IE42043B1/en unknown
- 1975-01-29 NL NL7501028A patent/NL7501028A/xx not_active Application Discontinuation
- 1975-01-30 NO NO750295A patent/NO750295L/no unknown
- 1975-01-30 BE BE152864A patent/BE824970A/fr not_active IP Right Cessation
- 1975-01-31 FI FI750260A patent/FI750260A7/fi not_active Application Discontinuation
- 1975-02-01 ES ES434384A patent/ES434384A1/es not_active Expired
- 1975-02-03 DE DE19752504373 patent/DE2504373A1/de not_active Withdrawn
- 1975-02-03 GB GB453575A patent/GB1439742A/en not_active Expired
- 1975-02-03 LU LU71784A patent/LU71784A1/xx unknown
- 1975-02-03 JP JP50014790A patent/JPS50107122A/ja active Pending
- 1975-02-03 AT AT76675A patent/AT338416B/de not_active IP Right Cessation
- 1975-02-03 DD DD183973A patent/DD116474A5/xx unknown
- 1975-02-03 HU HUTE805A patent/HU170522B/hu unknown
- 1975-02-03 CS CS75669A patent/CS202545B2/cs unknown
- 1975-02-03 CH CH124275A patent/CH596316A5/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK141926C (fr)	1981-01-19
FR2259616A1 (fr)	1975-08-29
DK9775A (fr)	1975-09-29
SE7500549L (fr)	1975-08-05
NL7501028A (nl)	1975-08-06
DK141926B (da)	1980-07-21
IE42043B1 (en)	1980-05-21
ES434384A1 (es)	1976-12-01
DD116474A5 (fr)	1975-11-20
BE824970A (fr)	1975-07-30
FR2259616B1 (fr)	1980-01-04
AT338416B (de)	1977-08-25
SE424503B (sv)	1982-07-26
DE2504373A1 (de)	1975-08-07
FI750260A7 (fr)	1975-08-05
AU7734675A (en)	1976-07-15
CH596316A5 (fr)	1978-03-15
GB1439742A (en)	1976-06-16
ZA75248B (en)	1976-01-28
CA1047922A (fr)	1979-02-06
JPS50107122A (fr)	1975-08-23
NO750295L (fr)	1975-09-01
LU71784A1 (fr)	1975-06-24
IE42043L (en)	1975-08-04
HU170522B (fr)	1977-06-28
ATA76675A (de)	1976-12-15
IL46446A0 (en)	1975-04-25
IL46446A (en)	1978-01-31

Publication	Publication Date	Title
US4530831A (en)	1985-07-23	Infectious Bursal Disease vaccine
US6919084B2 (en)	2005-07-19	Duck pneumovirus and corresponding vaccines
US4009258A (en)	1977-02-22	Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
US5807551A (en)	1998-09-15	Method to provide artificial passive immunity in birds
US4302444A (en)	1981-11-24	Vaccines for immunizing egg-laying birds against Egg Drop disease, preparation of said vaccines, and method of use of said vaccines
Atanasiu et al.	1961	Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons: Part 3
HU189222B (en)	1986-06-30	Process for preparing a new vaccine against infectious bronchytis
US3953592A (en)	1976-04-27	Live influenza virus vaccines and preparation thereof
IE51122B1 (en)	1986-10-15	Infectious-bronchitis vaccines for poultry,combined infectious-bronchitis vaccines,process for preparing such vaccines,method for preventing infectious bronchitis,and infectious-bronchitis virus strains
AU705186B2 (en)	1999-05-20	Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
JP3945842B2 (ja)	2007-07-18	弱毒性ニューカッスル病ウイルスワクチン
US20120107354A1 (en)	2012-05-03	Viral vaccine and process for preparing the same
US3962423A (en)	1976-06-08	Live influenza type B virus vaccines and preparation thereof
CS199569B2 (en)	1980-07-31	Method of producing vaccine against influenza
MXPA96003124A (en)	1997-06-01	Vaccine against the newcastle beni disease virus
EP0009277B1 (fr)	1984-04-18	Vaccin combiné actif contre la maladie de Newcastle et contre la baisse de la ponte causée par des virus du genre adéno, procédé de préparation, souches de virus du genre adéno et de la maladie de Newcastle
Crick	1973	The vaccination of man and other animals against rabies
US3769400A (en)	1973-10-30	Process for the manufacture of a live vaccine against the infectious bursitis of chickens
US4554158A (en)	1985-11-19	Modified live sendai virus vaccine for administering through an aerosol and method of producing the same
EP0292210A2 (fr)	1988-11-23	Virus atténué et vaccin pour utilisation contre les infections de la volaille causées par le virus de la rhinotrachéite du dindon
RU2259844C1 (ru)	2005-09-10	Вирус-вакцина против ньюкаслской болезни птиц
IE42043B1 (en)	1980-05-21	Influenza type b virus vaccines and preparation thereof
JPS62201573A (ja)	1987-09-05	家禽用インフルエンザワクチン
JPS6244528B2 (fr)	1987-09-21
USRE34013E (en)	1992-07-28	Infectious bronchitis vaccine for poultry